Evangelou, G.; Trontzas, I.P.; Gkiozos, I.; Vamvakaris, I.; Paraskeva, C.; Grammoustianou, M.; Gomatou, G.; Tsamis, I.; Vathiotis, I.; Anagnostakis, M.;
et al. The Effectiveness of Atezolizumab in Metastatic Large Cell Neuroendocrine Carcinoma of the Lungs: Insights from the LANCE Pilot Study. Biomedicines 2024, 12, 1161.
https://doi.org/10.3390/biomedicines12061161
AMA Style
Evangelou G, Trontzas IP, Gkiozos I, Vamvakaris I, Paraskeva C, Grammoustianou M, Gomatou G, Tsamis I, Vathiotis I, Anagnostakis M,
et al. The Effectiveness of Atezolizumab in Metastatic Large Cell Neuroendocrine Carcinoma of the Lungs: Insights from the LANCE Pilot Study. Biomedicines. 2024; 12(6):1161.
https://doi.org/10.3390/biomedicines12061161
Chicago/Turabian Style
Evangelou, Georgios, Ioannis P. Trontzas, Ioannis Gkiozos, Ioannis Vamvakaris, Christina Paraskeva, Maria Grammoustianou, Georgia Gomatou, Ioannis Tsamis, Ioannis Vathiotis, Maximillian Anagnostakis,
and et al. 2024. "The Effectiveness of Atezolizumab in Metastatic Large Cell Neuroendocrine Carcinoma of the Lungs: Insights from the LANCE Pilot Study" Biomedicines 12, no. 6: 1161.
https://doi.org/10.3390/biomedicines12061161
APA Style
Evangelou, G., Trontzas, I. P., Gkiozos, I., Vamvakaris, I., Paraskeva, C., Grammoustianou, M., Gomatou, G., Tsamis, I., Vathiotis, I., Anagnostakis, M., Koliaraki, V., & Syrigos, K.
(2024). The Effectiveness of Atezolizumab in Metastatic Large Cell Neuroendocrine Carcinoma of the Lungs: Insights from the LANCE Pilot Study. Biomedicines, 12(6), 1161.
https://doi.org/10.3390/biomedicines12061161
